Clinical trials: Ganciclovir Eye Drops

Cytomegalovirus Retinitis, Ganciclovir Eye Drops

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

• Recruiting
• Age: 2 to 80 years
• Early Phase 1

Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis

Trial name

NCT05911503

Testing

2% Ganciclovir Eye Drops

Where

China

Volunteers

15 people

Sponsor

Tianjin Medical University